Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display

4001 - Effect of mindfulness training on quality of life and distress in early breast cancer patients treated with endocrine therapy


09 Oct 2016


Poster display


Jeroen Mebis


Annals of Oncology (2016) 27 (6): 469-473. 10.1093/annonc/mdw386


J. Mebis1, S. Censabella2, N. Cardinaels2, G. Orye3, S. Marquette3, L. Noe2, A. Maes2, P. Bulens2

Author affiliations

  • 1 Division Of Medical Oncology, Jessa Hospital, 3500 - Hasselt/BE
  • 2 Limburg Oncology Center, Jessa Hospital, 3500 - Hasselt/BE
  • 3 Gynecology, Jessa Hospital, 3500 - Hasselt/BE


Abstract 4001


Endocrine therapy (ET) prescribed in breast cancer can cause side effects that mimic menopausal symptoms and can thereby affect patients' quality of life. Mindfulness-Based Stress Reduction (MBSR) is a structured group intervention based on meditation and its application in daily life. It has been shown effective in improving quality of life (QoL) and reducing psychological distress in cancer patients but not specifically in patients receiving ET, which was the aim of this study.


Newly diagnosed breast cancer patients scheduled for (any) ET and/ or radio- but no chemotherapy were recruited to participate in a standardized, 8-week MBSR program provided by a certified trainer (one 3h-session/ week). Clinical outcomes were general QoL and distress measured through the short World Health Organisation Quality of Life scale (WHOQOL-Bref) and the short revised Depression Anxiety Stress Scales (DASS-21-R) before the start, at the end, and 6 months after the end of MBSR.


Twenty breast cancer patients, all receiving tamoxifen (11 had also radiotherapy), completed the study. Mean age was 57.5 ± 7.4 years. At the start of MBSR, 11 were postmenopausal, mean time since diagnosis was 157 ± 65 days and mean time on ET was 99 ± 68 days. As shown in Table 1, the WHOQOL-Bref total score did not improve after MBSR. In contrast, there was a significant decrease of the DASS-21-R total score, though only the comparison of scores before the start vs after 6 months reached significance (p = 0.023, two-tailed paired Wilcoxon tests; scores before vs after MBSR: p = 0.186).

Mean scores for global QOL and psychological distress of patients treated with tamoxifen receiving MBSR

Outcome Before start of MBSR At end of MBSR 6-month after end of MBSR P (Friedman ANOVA, two tailed)
WHOQO-Bref total score 97.4(10) 96.4(8.3) 98.9(10.4) 0.170
DASS-21-R Total score 28(14.8) 22.5(13.4) 19.5(17.4) 0.030


MBSR did not improve global QoL in breast cancer patients treated with tamoxifen. Given their rather high QoL MBSR might not have been offered at an appropriate time. Still, MBSR was beneficial as it significantly lowered their psychological distress (up to at least 6 months).

Clinical trial identification

Legal entity responsible for the study

Jeroen Mebis


VZW Think Pink


All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings